Impact of Fasudil on Prevention of Vasospasm in Patients with Subarachnoid Hemorrhage:a Systematic Review and Meta-Analysis

Ming-Quan LI,Lei SHU,Zeng-Jun LIU,Ling LIU,Xiao-Xia WANG,Xin-Yi WANG,Ming ZHAO
DOI: https://doi.org/10.3969/j.issn.1673-5765.2015.01.008
2015-01-01
Abstract:Objective To assess the validity of fasudil on preventing vasospasm in patients with subarachnoid hemorrhage. Methods We searched eligible literatures and abstracted data from MEDLINE, EMBASE, Google Scholar and China Biology Medicine disc, and synthesized with Stata 12.0 for meta-analysis by random effect model. Results Seven studies included 709 patients were included in ifnal analysis. When compared with the control group, the incidence of vasospasm in fasudil group was associated with a risk ratio (RR) of 0.54, 95%CI (0.38, 0.77),P<0.05. Meanwhile, there was no risk difference of vasospasm found in stratiifed analysis by revised Jadad score above 4, countries (China and Japan), and nimodipine as control group intervention. Conclusion Fasudil in subarachnoid hemorrhage patients may reduce vasospasm incidence. But we failed to demonstrate a signiifcant reduction in stratiifed analysis.
What problem does this paper attempt to address?